Data as of Oct 24
| +1.13 / +2.15%|
The 19 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 56.00, with a high estimate of 63.00 and a low estimate of 34.00. The median estimate represents a +4.42% increase from the last price of 53.63.
The current consensus among 23 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since October, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.